Description
Developer of molecular diagnostics technology based in Salt Lake City, Utah. The company revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics.
Contact Information
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20170112881-A1 | Method of treating endometriosis | Abandoned | 06-Jan-2016 | 000000000 | |
US-20160022696-A1 | Therapeutic and method of use | Granted | 21-May-2013 | 0000000000 | |
US-20140348957-A1 | Therapeutic and method of use | Granted | 21-May-2013 | 0000000000 | |
EP-3943079-A1 | Therapeutic and method of use | Pending | 21-May-2013 | 0000000000 | |
AU-2019246858-A1 | Therapeutic and method of use | Abandoned | 21-May-2013 | A61K31/567 |
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 000000 | 12-Apr-2016 | 0000000000 | Biotechnology |